HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mahya Eslami Selected Research

Tumor Necrosis Factor Ligand Superfamily Member 13

1/2021APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mahya Eslami Research Topics

Disease

1Neoplasms (Cancer)
01/2024
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1Atherosclerosis
01/2021
1Anhidrotic Ectodermal Dysplasia 1
01/2021
1Atherosclerotic Plaque (Atheroma)
01/2021
1Inflammation (Inflammations)
01/2021

Drug/Important Bio-Agent (IBA)

1LDL Lipoproteins (beta Lipoproteins)IBA
01/2021
1CytokinesIBA
01/2021
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
01/2021
1B-Cell Activating FactorIBA
01/2021
1Tumor Necrosis Factor Ligand Superfamily Member 13IBA
01/2021
1EctodysplasinsIBA
01/2021
1Heparitin Sulfate (Heparan Sulfate)IBA
01/2021

Therapy/Procedure

1Therapeutics
01/2024